| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Royal Victoria Hospital and McGill University Clinic, Montreal, Quebec H3A 1A1, Canada, [S. Y. M., R. P., M. A. Y., S. M.] and Department of Biochemistry, Howard University School of Medicine, Washington, D. C. 20059 [H. P. M.]
The local growth rate of Morris Hepatoma 44 (generation time, 6 months) was inhibited by 66 to 87%, and host survival was prolonged by 36 to 78% after the induction of hypothyroidism within 2 weeks of tumor implantation by propylthiouracil (0.1% in Purina chow), 131I (1 mCi/100 g body weight i.p.), or surgical thyroidectomy. In additional experiments, we studied the effects of inducing hypothyroidism (131I) at different stages in the natural history of Morris Hepatoma 44 on local and metastatic growth as well as on host survival. Induction of hypothyroidism within 2 weeks of tumor implantation (Group I) reduced local tumor growth as well as the number and size of pulmonary metastases, and prolonged survival by 70 to 80%. Induction of hypothyroidism at 6 weeks postimplantation when tumors were palpable (Group II) inhibited local growth by 39%, reduced the number and size of pulmonary metastases by approximately 80%, and prolonged host survival by 35%. Initiation of 131I treatment at 11 weeks when microscopic pulmonary emboli were present in most animals (Group III) reduced local growth by 19% and the number and size of pulmonary metastases by 72 and 50%, respectively. In this case, survival was prolonged by 17%. We conclude from these results that the local and metastatic growth of Morris Hepatoma 44 as well as host survival are thyroid hormone-dependent processes. The mechanisms responsible for these observations remain to be explained.
1 This study was supported by grants from the National Cancer Institute of Canada and USPHS Grant CA 10729, and is dedicated to the memory of Moe Yalovsky.
2 Chercheur Boursier of the Quebec Medical Research Council. To whom requests for reprints should be addressed, at the Department of Medicine, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1.
Received 11/10/80. Accepted 4/22/81.
This article has been cited by other articles:
![]() |
M. Nelson, A. Hercbergs, L. Rybicki, and M. Strome Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1041 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-h. Lin, H.-y. Shieh, and H.-C. Hsu Negative Regulation of the Antimetastatic Gene Nm23-H1 by Thyroid Hormone Receptors Endocrinology, July 1, 2000; 141(7): 2540 - 2547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |